| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 178,551 | 159,169 | 220,044 | 191,234 | | Cost of Revenue | 117,564 | 109,961 | 150,810 | 135,687 | | | Gross Profit | 60,987 | 49,208 | 69,234 | 55,547 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 48,704 | 47,700 | 54,374 | 54,311 | | Non Recurring |
-
|
-
|
-
| 22,299 | | Others | 3,292 | 3,390 | 3,623 | 3,886 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,991 | (1,882) | 11,237 | (24,949) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (234) | | Earnings Before Interest And Taxes | 8,991 | (1,882) | 11,237 | (25,183) | | Interest Expense | 4,711 | 3,966 | 4,618 | 4,357 | | Income Before Tax | 4,280 | (5,848) | 6,619 | (29,540) | | Income Tax Expense | (26) | (694) | 827 | (7,970) | | Minority Interest | (265) |
-
|
-
| (47) | | | | Net Income From Continuing Ops | 4,041 | (5,154) | 5,792 | (21,617) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,041 | (5,154) | 5,792 | (21,617) | | Preferred Stock And Other Adjustments | 97 | (154) | 57 |
-
| | | Net Income Applicable To Common Shares | $4,138 | ($5,308) | $5,849 | ($21,617) |
|
0.03% Nasdaq 
Income Statement
